Pre-clinical development of
Listeria
immunotherapy
melanoma
nanoparticles
therapeutic vaccination
Journal
Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
Historique:
received:
09
05
2018
revised:
15
10
2018
accepted:
24
10
2018
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
5
2
2019
Statut:
epublish
Résumé
Gold glyconanoparticles loaded with the listeriolysin O peptide 91-99 (GNP-LLO
Identifiants
pubmed: 30713801
doi: 10.1080/2162402X.2018.1541534
pii: 1541534
pmc: PMC6343812
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e1541534Références
Nature. 2014 Nov 27;515(7528):577-81
pubmed: 25428507
PLoS One. 2012;7(3):e32310
pubmed: 22403645
Oncotarget. 2017 Mar 28;8(13):20729-20740
pubmed: 28186976
Oncology (Williston Park). 2009 May;23(6):488-96
pubmed: 19544689
Immunity. 2011 Aug 26;35(2):236-48
pubmed: 21867927
Vaccine. 2015 Mar 17;33(12):1465-73
pubmed: 25659269
Oncol Rep. 2012 Oct;28(4):1131-8
pubmed: 22895835
J Transl Med. 2014 Jul 22;12:209
pubmed: 25053129
Clin Cancer Res. 2013 Nov 15;19(22):6151-62
pubmed: 24030703
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Cancer Res. 2009 Jul 15;69(14):5860-6
pubmed: 19584282
Sci Transl Med. 2015 Apr 15;7(283):283ra52
pubmed: 25877890
J Clin Oncol. 2015 Apr 20;33(12):1325-33
pubmed: 25584002
Nanomaterials (Basel). 2016 Aug 19;6(8):
pubmed: 28335280
Chemistry. 2009 Sep 28;15(38):9874-88
pubmed: 19681073
Chembiochem. 2009 Jul 20;10(11):1806-9
pubmed: 19565596
J Exp Med. 2011 Sep 26;208(10):1989-2003
pubmed: 21930769
Front Immunol. 2015 Mar 30;6:144
pubmed: 25870600
Immunol Res. 2008;42(1-3):233-45
pubmed: 19018479
Nanoscale. 2017 Aug 3;9(30):10721-10732
pubmed: 28714508
J Transl Med. 2005 Jan 28;3(1):4
pubmed: 15676080
Hum Vaccin Immunother. 2016 Apr 2;12(4):1085-6
pubmed: 26618528
Nanomedicine (Lond). 2017 Jan;12(1):13-23
pubmed: 27879152
J Am Chem Soc. 2013 Jun 26;135(25):9362-5
pubmed: 23763610
Genes Chromosomes Cancer. 2017 Aug;56(8):651-659
pubmed: 28466543
Acta Derm Venereol. 2008;88(1):92-3
pubmed: 18176770
Front Immunol. 2015 Feb 09;6:46
pubmed: 25709607
EFSA J. 2017 Dec 12;15(12):e05077
pubmed: 32625371
Nanomedicine (Lond). 2012 May;7(5):651-62
pubmed: 22630149
Chem Soc Rev. 2013 Jun 7;42(11):4728-45
pubmed: 23288339
PLoS One. 2015 Mar 11;10(3):e0117923
pubmed: 25760947
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
Bioconjug Chem. 2012 Aug 15;23(8):1513-23
pubmed: 22812418
Front Cell Infect Microbiol. 2014 May 12;4:51
pubmed: 24860789
Oncotarget. 2016 Mar 29;7(13):16855-65
pubmed: 26942874
Cancer Res. 2013 Jan 1;73(1):139-49
pubmed: 23149919
Ther Adv Vaccines. 2013 Nov;1(4):131-43
pubmed: 24757520
Cancer Immunol Res. 2016 Oct;4(10):845-857
pubmed: 27589875
Cell. 2017 Sep 7;170(6):1109-1119.e10
pubmed: 28886381
Chembiochem. 2004 Mar 5;5(3):291-7
pubmed: 14997521
Science. 2016 May 6;352(6286):658-60
pubmed: 27151852
PLoS One. 2016 Sep 09;11(9):e0161779
pubmed: 27610613
Hum Vaccin Immunother. 2013 May;9(5):1058-68
pubmed: 23399758
Carbohydr Res. 2007 Feb 26;342(3-4):448-59
pubmed: 17173881
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Cancer Immunol Immunother. 2014 Sep;63(9):959-67
pubmed: 24878889
Oncotarget. 2017 Jul 20;8(33):53916-53934
pubmed: 28903312
Neoplasma. 2002;49(3):159-66
pubmed: 12098001
Nanomedicine. 2015 Feb;11(2):447-56
pubmed: 25194998
Front Immunol. 2016 Nov 29;7:541
pubmed: 27965668